Insider Trading activities at Scynexis Inc (SCYX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Scynexis Inc (SCYX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Scynexis Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1178253.

Total stock buying since 2014: $13,353,340.
Total stock sales since 2014: $4,804,695.
Total stock option exercises since 2014: $0.


17 insiders reported insider trading activities at Scynexis Inc (SCYX):
Insider trading activities of Fcpr Biotechnology Fund
Insider trading activities of Angulo Gonzalez David
Insider trading activities of Francois Eric
Insider trading activities of Sukenick Scott
Insider trading activities of Ventech Capital Ii
Insider trading activities of Nothias Jean-yves
Insider trading activities of F.c.p.r. Genavent
Insider trading activities of Champsi Farah
Insider trading activities of Hastings David C
Insider trading activities of Taglietti Marco
Insider trading activities of Gilman Steven C
Insider trading activities of Anido Armando
Insider trading activities of Hanham Ann
Insider trading activities of Machado Clarence Patrick
Insider trading activities of Edelman Joseph
Insider trading activities of Tinmouth Brian Philippe
Insider trading activities of Macdonald Guy

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Scynexis Inc (SCYX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 20,000 $27,400 0 $0 0 $0
2022 78,500 $235,500 0 $0 0 $0
2021 0 $0 599,000 $4,804,695 0 $0
2020 72,000 $450,000 0 $0 0 $0
2019 236,682 $229,215 0 $0 0 $0
2018 224,500 $315,205 0 $0 0 $0
2017 95,000 $165,898 0 $0 0 $0
2016 310,421 $809,754 0 $0 0 $0
2015 103,000 $740,368 0 $0 0 $0
2014 1,038,000 $10,380,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Scynexis Inc (SCYX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2024-09 20,000 $27,400 0 $0 0 $0
2022-04 78,500 $235,500 0 $0 0 $0
2021-01 0 $0 599,000 $4,804,695 0 $0
2020-12 72,000 $450,000 0 $0 0 $0
2019-12 166,667 $150,000 0 $0 0 $0
2019-08 20,015 $21,215 0 $0 0 $0
2019-04 25,000 $40,750 0 $0 0 $0
2019-01 25,000 $17,250 0 $0 0 $0
2018-12 37,000 $17,452 0 $0 0 $0
2018-09 7,000 $8,890 0 $0 0 $0
2018-08 25,000 $32,250 0 $0 0 $0
2018-03 155,500 $256,613 0 $0 0 $0
2017-09 10,000 $22,300 0 $0 0 $0
2017-08 25,000 $40,848 0 $0 0 $0
2017-06 20,000 $35,000 0 $0 0 $0
2017-05 40,000 $67,750 0 $0 0 $0
2016-12 29,000 $95,500 0 $0 0 $0
2016-09 40,000 $117,600 0 $0 0 $0
2016-06 211,950 $500,408 0 $0 0 $0
2016-05 29,471 $96,246 0 $0 0 $0
2015-11 22,733 $154,434 0 $0 0 $0
2015-09 3,000 $21,000 0 $0 0 $0
2015-08 77,267 $564,934 0 $0 0 $0
2014-05 1,038,000 $10,380,000 0 $0 0 $0

Table 3. Detailed insider trading at Scynexis Inc (SCYX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-09-12 Angulo Gonzalez David (Chief Executive Officer) Buy 20,000 1.37 27,400
2022-04-26 Sukenick Scott (General Counsel) Buy 3,500 3.00 10,500
2022-04-26 Taglietti Marco (Chief Executive Officer) Buy 75,000 3.00 225,000
2021-01-22 Edelman Joseph (10% Owner) Sale 319,000 8.55 2,729,045
2021-01-21 Edelman Joseph (10% Owner) Sale 95,000 7.38 701,100
2021-01-20 Edelman Joseph (10% Owner) Sale 185,000 7.43 1,374,550
2020-12-21 Tinmouth Brian Philippe (Director) Buy 8,000 6.25 50,000
2020-12-21 Sukenick Scott (General Counsel) Buy 1,600 6.25 10,000
2020-12-21 Francois Eric (Chief Financial Officer) Buy 600 6.25 3,750
2020-12-21 Angulo Gonzalez David (Chief Medical Officer) Buy 1,600 6.25 10,000
2020-12-21 Taglietti Marco (Chief Executive Officer) Buy 40,000 6.25 250,000
2020-12-21 Gilman Steven C (Director) Buy 4,000 6.25 25,000
2020-12-21 Macdonald Guy (Director) Buy 8,000 6.25 50,000
2020-12-21 Hanham Ann (Director) Buy 3,200 6.25 20,000
2020-12-21 Anido Armando (Director) Buy 5,000 6.25 31,250
2019-12-12 Taglietti Marco (Chief Executive Officer) Buy 166,667 .90 150,000
2019-08-21 Taglietti Marco (Chief Executive Officer) Buy 9,500 1.11 10,545
2019-08-20 Taglietti Marco (Chief Executive Officer) Buy 500 1.11 555
2019-08-15 Taglietti Marco (Chief Executive Officer) Buy 10,015 1.01 10,115
2019-04-17 Taglietti Marco (Chief Executive Officer) Buy 25,000 1.63 40,750
2019-01-10 Taglietti Marco (Chief Executive Officer) Buy 25,000 .69 17,250
2018-12-31 Angulo Gonzalez David (Chief Medical Officer) Buy 12,000 .50 5,952
2018-12-31 Taglietti Marco (Chief Executive Officer) Buy 25,000 .46 11,500
2018-09-06 Angulo Gonzalez David (Chief Medical Officer) Buy 7,000 1.27 8,890
2018-08-23 Taglietti Marco (Chief Executive Officer) Buy 25,000 1.29 32,250
2018-03-29 Angulo Gonzalez David (Chief Medical Officer) Buy 6,000 1.36 8,160
2018-03-08 Sukenick Scott (General Counsel) Buy 2,959 1.69 5,000
2018-03-08 Francois Eric (Chief Financial Officer) Buy 5,917 1.69 9,999
2018-03-08 Angulo Gonzalez David (Chief Medical Officer) Buy 21,790 1.54 34,725
2018-03-08 Taglietti Marco (Chief Executive Officer) Buy 100,000 1.69 169,000
2018-03-08 Hastings David C (Director) Buy 11,834 1.69 19,999
2017-09-22 Taglietti Marco (Chief Executive Officer) Buy 10,000 2.23 22,300
2017-08-23 Taglietti Marco (Chief Executive Officer) Buy 4,993 1.85 9,237
2017-08-22 Taglietti Marco (Chief Executive Officer) Buy 7 1.61 11
2017-08-15 Taglietti Marco (Chief Executive Officer) Buy 10,000 1.61 16,100
2017-08-11 Angulo Gonzalez David (Chief Medical Officer) Buy 10,000 1.55 15,500
2017-06-21 Hastings David C Buy 20,000 1.75 35,000
2017-05-12 Angulo Gonzalez David (Chief Medical Officer) Buy 15,000 1.70 25,500
2017-05-12 Taglietti Marco (Chief Executive Officer) Buy 25,000 1.69 42,250
2016-12-21 Taglietti Marco (Chief Executive Officer) Buy 25,000 3.30 82,500
2016-12-16 Angulo Gonzalez David (Chief Medical Officer) Buy 4,000 3.25 13,000
2016-09-15 Machado Patrick Buy 40,000 2.94 117,600
2016-06-30 Angulo Gonzalez David (Chief Medical Officer) Buy 32,150 2.23 71,694
2016-06-29 Angulo Gonzalez David (Chief Medical Officer) Buy 4,800 2.18 10,464
2016-06-24 Francois Eric (Chief Financial Officer) Buy 15,000 2.39 35,850
2016-06-24 Taglietti Marco (Chief Executive Officer) Buy 100,000 2.39 239,000
2016-06-24 Machado Clarence Patrick Buy 20,000 2.39 47,800
2016-06-24 Macdonald Guy Buy 40,000 2.39 95,600
2016-05-25 Taglietti Marco (Chief Executive Officer) Buy 6,000 3.23 19,545
2016-05-25 Hanham Ann Buy 4,225 3.64 15,379
2016-05-24 Taglietti Marco (Chief Executive Officer) Buy 5,500 3.37 18,535
2016-05-23 Taglietti Marco (Chief Executive Officer) Buy 3,000 3.15 9,450
2016-05-20 Taglietti Marco (Chief Executive Officer) Buy 4,500 3.14 14,130
2016-05-19 Taglietti Marco (Chief Executive Officer) Buy 6,000 3.07 18,420
2015-11-24 Taglietti Marco (Chief Executive Officer) Buy 7,733 6.80 52,584
2015-11-23 Taglietti Marco (Chief Executive Officer) Buy 15,000 6.79 101,850
2015-09-15 Angulo Gonzalez David (Chief Medical Officer) Buy 3,000 7.00 21,000
2015-08-31 Taglietti Marco (Chief Executive Officer) Buy 25,000 7.82 195,500
2015-08-28 Taglietti Marco (Chief Executive Officer) Buy 400 7.15 2,860
2015-08-27 Taglietti Marco (Chief Executive Officer) Buy 1,867 7.07 13,199
2015-08-26 Taglietti Marco (Chief Executive Officer) Buy 25,000 6.98 174,500
2015-08-25 Taglietti Marco (Chief Executive Officer) Buy 25,000 7.16 178,875
2014-05-07 Ventech Capital Ii (10% Owner) Buy 28,000 10.00 280,000
2014-05-07 F.c.p.r. Genavent (10% Owner) Buy 10,000 10.00 100,000
2014-05-07 Fcpr Biotechnology Fund (10% Owner) Buy 50,000 10.00 500,000
2014-05-07 Nothias Jean-yves (Director) Buy 50,000 10.00 500,000
2014-05-07 Champsi Farah (10% Owner) Buy 900,000 10.00 9,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of SCYX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Scynexis Inc (symbol SCYX, CIK number 1178253) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.